POST LEONARD E — SEC Form 4 filings
SEC reporting owner CIK 1235862. 26 Form 4 filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 26 filings on record, filed 2024-06-18 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 23 legs across 22 filings — 38,327 shares, $1,656,702 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 47.
- Largest priced transaction: sale of 5,000 shares @ $70.00 ($350,000) in CG Oncology, Inc., filed 2026-06-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CG Oncology, Inc. (CGON) | Director | 21 | — | 20 legs · 32,000 sh · $1,560,832 | 41 |
| uniQure N.V. (QURE) | Director | 5 | — | 3 legs · 6,327 sh · $95,870 | 6 |
Form 4 filings — POST LEONARD E
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $72.98 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $74.54 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $71.17 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 5,000 @ $0.60 · Sale (S): 5,000 @ $70 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 5,000 @ $0.60 · Sale (S): 5,000 @ $65 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | uniQure N.V. (QURE) | Grant/award (A): 7,550 @ $0 · Sale (S): 1,993 @ $27.06 · Grant/award (A): 13,980 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $54.50 · Option exercise (M): 1,000 (derivative) @ $0 · Grant/award (A): 9,354 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $41.43 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $43.25 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-10-01 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 5,000 @ $0.60 · Sale (S): 5,000 @ $40.09 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-09-16 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $35.10 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-09-04 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $28 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-07-18 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 2,000 @ $0.60 · Sale (S): 2,000 @ $28 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | uniQure N.V. (QURE) | Sale (S): 2,112 @ $14.45 | EDGAR |
| 2025-06-13 | 4 | uniQure N.V. (QURE) | Grant/award (A): 7,970 @ $0 · Grant/award (A): 15,630 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | CG Oncology, Inc. (CGON) | Grant/award (A): 24,165 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $28 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-04-29 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $30.76 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $28 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $28.61 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2025-01-14 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $29.66 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-12-17 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $28.84 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-12-06 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 1,000 @ $0.60 · Sale (S): 750 @ $34.40 · Sale (S): 250 @ $34.98 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-10-07 | 4 | CG Oncology, Inc. (CGON) | Grant/award (A): 15,600 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | uniQure N.V. (QURE) | Grant/award (A): 8,080 @ $0 · Grant/award (A): 15,840 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | uniQure N.V. (QURE) | Sale (S): 2,222 @ $5.14 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1235862 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →